Givlaari Prices, Coupons and Patient Assistance Programs
Givlaari (givosiran) is a member of the miscellaneous metabolic agents drug class and is commonly used for Porphyria.
The cost for Givlaari subcutaneous solution (189 mg/mL) is around $43,577 for a supply of 1 milliliter(s), depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Givlaari is available as a brand name drug only, a generic version is not yet available. View generic Givlaari availability for more details.
Givlaari prices
Subcutaneous Solution
Quantity | Per unit | Price |
---|---|---|
1 milliliter | $43,577.38 | $43,577.38 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Givlaari Coupons, Copay Cards and Rebates
Givlaari offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Givlaari Copay Program
Eligible commercially insured patients may receive assistance with drug-related out-of-pocket expenses such as co-pays and co-insurance; for additional information contact the program at 833-256-2748.
- Applies to:
- Givlaari
- Number of uses:
- Per prescription until program expires
Form more information phone: 833-256-2748 or Visit website
Patient Assistance & Copay Programs for Givlaari
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Givlaari (givosiran) Injection; Subcutaneous
More information please phone: 800-675-8416 Visit Website
Provider: Alnylam Assist: GIVLAARI
Eligibility requirements:- Must be uninsured or rendered uninsured
- Not disclosed
- FDA-approved diagnosis
- The patient must also be a US resident.
- This program also provides co-pay assistance for eligible patients. Contact the program for more details.
- Givlaari (givosiran) Injection; Subcutaneous
More information please phone: 833-256-2748 Visit Website
More about Givlaari (givosiran)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español